PICC
Phase 2 Recruiting
270 enrolled
Phase II RCT of LCRT vs SCRT + CAPOX/PD-1i/COX-2i in MSS Locally Advanced Rectal Cancer
Phase 2 Recruiting
138 enrolled
PICC-3
Phase 2 Recruiting
105 enrolled
Chidamide + Celecoxib in Advanced Metastatic Colorectal Cancer (CCmCC)
Phase 1 Terminated
9 enrolled
DETECT
Phase 2 Unknown
29 enrolled
Chemokine-Modulatory Regimen for Recurrent Resectable Colorectal Cancer
Phase 1/2 Terminated
15 enrolled 9 charts
Molecular Targeting of 15-Lipoxygenase-1 (15-LOX-1) for Apoptosis Induction in Human Colorectal Cancers
Phase 2 Completed
51 enrolled 10 charts
HFS
Phase 3 Unknown
44 enrolled
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
Phase 3 Unknown
2,527 enrolled 14 charts
Celecoxib, Recombinant Interferon Alfa-2b, and Rintatolimod in Treating Patients With Colorectal Cancer Metastatic to the Liver
Phase 2 Completed
19 enrolled 15 charts
Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis
Phase 2 Completed
205 enrolled 16 charts
LDMchemoCRC
Phase 2 Completed
45 enrolled
Celecoxib in Preventing Colorectal Cancer in Young Patients With a Genetic Predisposition for Familial Adenomatous Polyposis
Phase 1 Completed
22 enrolled
Effect of Celecoxib on Perioperative Inflammatory Response in Colon Cancer
Phase NA Terminated
1 enrolled 3 charts
A Study of Type-1 Polarized Dendritic Cell (αDC1) Vaccine in Combination With Tumor-Selective Chemokine Modulation (Interferon-α2b, Rintatolimod, and Celecoxib) in Subjects With Chemo-Refractory Metastatic Colorectal Cancer
Phase 2 Withdrawn
Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer
Phase 1/2 Unknown
75 enrolled
UAB0040
Phase 2 Completed
40 enrolled 7 charts
Neoadjuvant Celecoxib and Capecitabine Combined With Pelvic Irradiation in Treating Patients With Stage II or Stage III Adenocarcinoma (Cancer) of the Rectum
Phase 2 Terminated
3 enrolled
Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer
Phase 3 Terminated
11 enrolled 7 charts
Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon
Phase 3 Completed
Combination Chemotherapy Treatments in Patients With Metastatic Colorectal Cancer
Phase 2 Completed
15 enrolled
Celecoxib in Preventing Cancer in Patients With Rectal Polyps or Colorectal Neoplasia
Phase 2 Completed
Celecoxib, Capecitabine, and Irinotecan in Treating Patients With Recurrent or Metastatic Colorectal Cancer
Phase 2 Completed
Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery
Phase 2 Completed
24 enrolled
Celecoxib in Treating Patients With Early-Stage Rectal Cancer
Phase NA Terminated
10 enrolled
Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal Cancer
Phase 1 Completed
2 enrolled
Celecoxib in Preventing Polyps in Patients Who Have Undergone Surgery for Stage I Colon Cancer
Phase 3 Terminated
18 enrolled
Cetuximab & Celecoxib for Metastatic Colorectal Cancer or Colorectal Cancer That Cannot Be Removed by Surgery
Phase 2 Completed
17 enrolled 15 charts
Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer
Phase 3 Completed
86 enrolled
Preoperative Non-steroidal Anti-inflammatory Drugs(NSAID) to Colorectal Cancer Patients
Phase 4 Completed
28 enrolled
Celebrex With Preoperative Chemoradiation - Rectal Cancer
Phase 1/2 Completed
39 enrolled
Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
Phase 2 Unknown
For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy
Phase 2 Terminated
212 enrolled
Phase I-II Multiple-Dose Safety and Efficacy Study of a Selective Inhibitor of Cyclooxygenase - 2 (SC-58635) in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients and Carriers
Phase 1 Completed
20 enrolled